Reddit Posts
The Cannabis Regulatory-Convergence Thesis
Higher Exchanges: Inside the DEA Rescheduling Hearings with Christian Bax
Inside the DEA Hearing: What Really Happened in the Cannabis Rescheduling Courtroom
Squeeze the shorts and create a Fomo run in Cannabis stocks
$MSOS might be the ugliest setup I actually like
D.C. Circuit challenge and DEA hearing put federal cannabis rescheduling to the test
DEA Marijuana Rescheduling Hearing Underway: New Day Five Short Summary
DEA Comes Out Swinging in Cannabis Rescheduling Hearing
Cannabis Rescheduling: The DEA Hearing That Could Pick Winners ft. Hirsh Jain
DEA Will Highlight Testimony On Marijuana's Medical Benefits In Rescheduling Hearing, New Filing Shows
DEA registration is a tough choice for medical marijuana operators
TCNNF, June 10th Uplisted to the NYSE.
Will weed stocks pump towards end of this month?
Cannabis groups file to partake in DEA rescheduling hearing (Newsletter: May 27, 2026)
Cresco Labs Marks Historic Step Forward with Medical Cannabis Facility DEA Registration
Cannabis Rescheduling: DOJ, Treasury, and DEA Updates
DEA Clarifies Intent of 'Red-Flag' Question on Medical Cannabis Schedule III Registration Application
LEEF Brands Files Applications for DEA Registration, Positioning for Interstate and Global Export Opportunities
LEEF Brands Hits Record Quarter | CEO & CFO Discuss DEA Exports, Expansion & 2026 Outlook
LEEF Brands Reports Strongest Quarter in Company History With Record Gross Profit, Margins, and Adjusted EBITDA
Cannabis Rescheduling, 280E and DEA Registration (with Hirsh Jain of Verdant Strategies)
DEA Will Start Accepting Applications From Medical Marijuana Businesses That Want Federal Rescheduling Protections This Week
The Fight for Cannabis Rescheduling Is Far From Over
Herbal Dispatch (HERB.CN / LUFFF) is GEARING UP for the U.S. Cannabis Boom!
DEA will hold a new administrative hearing beginning June 29, 2026, regarding the proposed rescheduling of marijuana.
NASDAQ : KALA ] Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine
Trump just signed an EO to fast-track psychedelics. ATAI ($1.4B) and GHRS ($1.04B) are Phase 3-ready with FDA Breakthrough designations.
I wouldn’t get my hopes up on the DEA/DOJ announcing anything on 420 folks.
I wouldn’t get my hopes up on the DEA/DOJ announcing anything on 420 folks.
I wouldn’t get my hopes up on the DEA/DOJ announcing anything on 420 folks.
Cannabis Industry : Schedule 3 Imminent according to Doug Kass and Anthony Martinelli
Is She High? Inside Pam Bondi's Hazy Performance as Attorney General...
MRMD: From Dispensary to Doctor's Office 🌳
His tooth is probably worth $5,000 now...
Elite Pharmaceuticals Schedules Q3 Fiscal 2026 Results Call
While you degens were staring at shiny rocks you missed the final act of one of the original WSB trades: Weed
Traders are about to get trapped in cannabis stocks, I fear
Cannabis is going to the Supreme Court on December 15th
U.S. Supreme Court To Discuss Case Challenging Federal Marijuana Prohibition December 15th. (MRMD)
Campo Indictment Exposes DEA Rotted From Within - While Medical Cannabis Research and Patients Wait Seven Years
Lawmakers could force the DEA to remove cannabis from the Schedule-1 list, with a 90-day time limit, to allow the FDA to study it for medical value so insurance companies can help patients obtain it at hospitals and pharmacies.
MRMD is a Maryland Medical Cannabis Company.
“The Medical Cannabis & Global Market Pathway”
Schedule III and the Chamber of Potions: The FDA Begins Advanced Herbology
I worked for GTBIF as an Assistant Manager of one of their dispensaries for medical cannabis and bought 50,000 shares of MRMD.
The DEA is holding cannabis back from being on Schedule-3
The DEA is holding cannabis back from being schedule-3.
Example: Medical Cannabis Rescheduling Act of 2026
Lawmakers could force the DEA to remove cannabis from the Schedule-1 list, with a 90-day time limit, to allow the FDA to study it for medical value so insurance companies can help patients obtain it at hospitals and pharmacies such as Walgreens, Costco, or CVS.
🚨 DEA Cannabis Rescheduling Update: Next 90-Day Status Report Expected Late October
500 $MSOS Dec Calls + Added $9 Strikes – Still Holding Strong 🌿🚀
Ban me if Cannabis does not get rescheduled in the next 30 days.
ELTP - Buyout This Year - Moonshot Valuation Assuming Foreign Buyer
The "2018 Farm Bill" accidentally legalized cannabis 🇺🇸
Yes, IXHL Ran Before… But DEA Rescheduling Could Change the Game for Real
Trump Deploys National Guard to DC, Takes Control of City Police
Why the Veteran's cannabis reform is irrelevant...
$IGC : It's never too late to get high
Weedmaps...Great Fundamentals and Under $1...6 Positive Qtrs Back to Back
Trump‑world PAC just ran a pro‑rescheduling video. Here’s why that matters
Trump’s New DEA Administrator Omits Cannabis Rescheduling From Top Priorities
MAKE TLRY GREAT AGAIN; THE CONSPIRACY/TURNAROUND THAT WSB WILL REMEMBER FOREVER
MAKE TLRY GREAT AGAIN; THE CONSPIRACY/TURNAROUND THAT WSB WILL REMEMBER FOREVER
DEA Judge Overseeing Marijuana Rescheduling Retires, Leaving Fate Of Reform To Trump’s New Agency Head
Mentions
Is this offer to ACB shareholders just days before the DEA ALJ's due date for a recommended decision on Rescheduling telling, or not?
Nice try DEA, that’s entrapment.
I’m not talking that case. I’m not really concerned with the ALJ hearing as the DEA will do what Trump wants.
MSOs have no idea how arduous the EU-GMP certification process really is. None of their facilities are built-out to any GACP/EU-GMP specs at the moment. That alone is a $2M-$5M opex investment. They'd still need to get an EU company to sponsor them, they'd send over their own QP, after they've been vetted then they would go to an EU regulator i.e. Germany via one of the various states. Each state is different and have their own, Cologne is very difficult but considered the gold standard. Even then if they were to get to that point, they are so backed up with other companies in Canada and abroad they're backed up 12-18 months before they could make their first visit and assessment. If it get's passed that and there's no major fixes, they'd send someone back again for the final inspection. If it get's past that it'll be another 90 days from there. U.S. regs are still a moving piece at the moment, you have to register with the DEA, get audited by them, approved etc., then move along the process. DEA has mutual recognition with a lot of EU countries, but medical cannabis in Europe only care that you're EU-GMP certified, they're beginning to crack down hard of GMP washing from Portugal. U.S. is 5 years away minimum before any type of exporting in my opinion.
Most people around this space are expecting the judge to submit his recommendation by August 29th, but this date is not set in stone, it could be earlier, right after August 17th or it could be later than August 29th. After that, it's entirely on the the DEA administrator, Terrance Cole, to issue a final rule if he wants to implement S3 for all of cannabis, or keep recreational cannabis as S1 as it currently is. After that, there should be judicial reviews as that's what the prohibitionists are going to be gunning for to stall this out. If the prohibitionists fails on their legal action, S3 should be fully implemented as the new law for cannabis...Timing of that is completely up for guessing, but my guess is by middle of October and not earlier than that.
What’s a little funny is I do think the DOJ / DEA is moving with all urgency 🤣 But I mean come on, the judge needs a few weeks after Aug 17 to say something…then the DEA even if they’re ready immediately does something on Sep to Oct timeframe That all seems like best case which is hard to get in the world of government… Meanwhile we have hopes but no clue as to how or when shares will appreciate
After this week max pain for MSOS is between $3.00 - $4.00 through November 20th. It sure looks like the options market doesn't think we'll have an ALJ / DEA outcome before then, and it's probably correct. [https://optioncharts.io/options/MSOS](https://optioncharts.io/options/MSOS)
https://www.washingtonpost.com/world/2026/07/27/operation-southern-spear-has-not-slowed-cocaine-entering-us/ "In a recent assessment reviewed by The Washington Post, DEA analysts found the strikes had failed to affect the supply or price of cocaine in the United States" WHAT HAPPENED TO DEALING WITH THE AFFORDABILITY CRISIS?!
In reality, SAM is totally locked out of this administration when this time 2 years ago Sabet was schmoozing with Milgram at DEA events.
*Ahem* https://www.marijuanamoment.net/federal-marijuana-rescheduling-hearing-wraps-up-with-dea-judge-laying-out-next-steps/ 30 days from now we will have the deadline for the ALJ hearings participants to submit briefs just for closing arguments, after that, if we get a recommendation on the same day, them it will be up for DEA administrator Terrance Cole to publish a final rule. If we get a positive final rule in our favor, then we will look forward to another 30 to 60 days for litigation and judicial reviews. If no delays and everything continues to go as smoothly as it did, everything should be wrapped up by mid October to end of October, again, right on time for midterms. Moreover: >The U.S. Department of the Treasury and Internal Revenue Service (IRS) said they plan to issue new tax guidance for the marijuana industry following rescheduling. The reform will benefit state-licensed marijuana businesses by allowing them to take federal tax deductions they’re currently barred from under an IRS code known as 280E that doesn’t apply to Schedule III substances. This doesn't says anything about tax guidance from previous years, but it's not bad to assume that this guidance should only come out after all of the process is over, Treasury has no reason to jump ahead of the final rule here unless THEY DO NOT want to grant relief from previous years.
I will only believe in this once we get the final rule recommendation and Terrance Cole(DEA administrator) to take up on it.
And unlike the previous admin. I don't expect the DEA to try and punt it.
Well...it is all guesswork at this point. I have been following closely, so will try and shed light on my 'educated' guess. The hearings just ended. They were closed door. I am shocked by how little coverage it got. Radio silence, even by those (MSOs) who will be impacted. I cannot help but think a 'gag order' was determined to be the best course of action by the CEOs. We've all seen what happens when someone raises Trump's ire. From what little I read, it seems as though the DEA was pretty straightforward about their rationale for S3...medical. I expect it will take at least a month to six weeks. First week of September is what I surmise...but like pretty much everything else in this sector, I vastly underestimated the levels of fuckery that have transpired, from fake walls to sniffer dogs to MSOS landing a penny or two just under max pain week in and week out.
I am guessing ALJ will deliberate and deliver Friday. But with the DEA maybe will be a few more years. Psh
There was no case for S1 for decades and it stayed there haha There’s a very strong case for S3 (and more) The difference isn’t the evidence, it’s that the DEA is pushing it instead of opposing it When this finally happens idk how I’ll even feel 😂
"Anyone" on this subreddit who suggests "everyone" is doing something clearly does not know "anything" about "everything". I can only speak for "myself" as I don't know "anyone else" on this subreddit...it's not like we all go out to coffee together and discuss weedstocks or meet in someone's basement and do cult things. Nope, just making posts on weedstocks. I've been here since 2018 (in and out of LPs and MSOs as well as MSOS). I have had a few major wins (rode the Constellation 5B in Canopy taking me from 35 a share to 70 a share) and Aphria in 2021 from 8 to 18 (I jumped early on its way to 33...which would equate to 330 pre-split) but I also got burned big time. I was out on margin in anticipation of what was "supposedly" a sure thing (was even reported in the Globe and Mail) with a cigarette company about to do a major investment in Aphria only to get burned by Hindenburg. Then the whole carmalized lungs due to vaping fiasco. I think I can make a qualified guess that most retail investors have moved on to other sectors. Ten years of false hope and rug pulls. Personally, I am checking in far less, but not quite throwing in the towel just yet. I find it unbelievable we are a day before the S3 hearings wrap up and running at such low volume. This was the holy grail in 2021 when Biden got elected. I cannot see what could possibly happen in this sector that would ignite interest to the same levels of 2018 and 2021. Donald Trump could make a 3am Truth Social post about descheduling cannabis altogether and I think it would be met with a collective "meh". How long did the 20% tariff on the Strait of Hormuz idea last? Oh, that's right, all part of the "Art of the Deal". What a schmuck. I am an American citizen, and I cannot get over what a clownshow our government has made of cannabis reform...and not just the Trump train. Nixon made marijuana a Schedule 1 drug at the stroke of a pen to get 'hippies' and persons of color off the streets (where they were demonstrating against the Vietnam War). NO supporting evidence whatsoever. Now Schedule 3 takes DEA hearings, votes in Congress and the Senate, and Executive Orders. Meanwhile close to half of the 50 states just moved on and legalized. The last ten years or so I have watched both Democrats and Republicans turn this into a cluster fuck. In truth, I am surprised most of these MSOs have lasted as long as they have. I am not surprised that most retail investors have decided to move on. I'm here because I think there will be a "mini rally" when S3 news hits sometime later this Fall and maybe, just maybe I can get out with less of a loss. I own Cresco (1.40CDN break even). MSOS (7USD break even). TLRY (9USD break even). My most recent sells were about two months ago with Charlotte's Web at .72CDN (made 5 cents a share) and Green Thumb at 11.17CDN (made 17 cents a share). Not even close to FOMO on either of these companies. I'm just glad I got out with a small profit. I think Cresco and MSOS will hit my break even points. 50/50 on Tilray getting back to 9USD, maybe 8USD? I am going to hold and let the S3 play out as I do believe it will happen. Then if there is that "mini rally" I have my sell orders preset and hopefully they will fill.
Really comes down to how they arrived at 3. 5 vs 2 part test. 2 part test has been used for other drugs if I understand correctly. Can anyone find a case where DEA/ALJ recommended a reclassification that was thrown out by another court? I believe that would be unprecedented? The financial interests in keeping weed schedule 1 are why we are where we are, that should be obvious and hopefully the courts will agree.
Recap is pretty consistent with what most expected - 1. ALJ recommends S3 2. Push for final rule to S3 3. Lawsuits from opposition DEA core argument is it doesn’t kill anyone, has medical uses and is being prescribed by physicians…even the opposition broadly agree with that 😅 There are a lot of good questions like regulation of potency, but that’s out of scope of this exercise
I am hopeful that once these hearings are completed we will start to see some of these companies (and their CEOs) start to speak out. I appreciate the radio silence as nobody in the industry wishes to tick off the politicians and DEA...but at some point they need to step up and provide more clarity. If the S3 hearings result in (eventually) a positive outcome, I suspect (hope) there will be interest once again. Until then...well, another red day while the market is green. Glad to see Charlotte's Web recovered 1.4% of its losses yesterday.
This video features an interview with journalist Natalie Fertig about her experience attending the recent DEA administrative hearing regarding the rescheduling of cannabis. The opposition spent hours methodically arguing against rescheduling by highlighting potential medical harms, such as teen psychosis. However, the DEA bypassed these extensive arguments and focused on just two core points: confirming that cannabis has not directly caused any fatal overdoses and establishing that it has potential medical use. By securing admissions on these two points, the DEA effectively demonstrated that cannabis does not meet the strict criteria to remain a Schedule I substance. **Key Details from the Hearing:** **The Setting \[**[**02:00**](https://www.youtube.com/watch?v=iU6p-u9xiAQ&t=120)**\]:** The hearing was incredibly dry and highly restricted, taking place in a sterile courtroom at the DEA headquarters in Pentagon City. Attendees had to sit in oversized pews and were barred from using laptops or phones. **The Opposition's Case \[**[**04:15**](https://www.youtube.com/watch?v=iU6p-u9xiAQ&t=255)**\]:** The anti-rescheduling side methodically presented years of studies and tragic personal testimonies (including a mother whose teenage son experienced a severe psychotic break) to argue that cannabis is dangerous. **The DEA's "Mic Drop" \[**[**06:50**](https://www.youtube.com/watch?v=iU6p-u9xiAQ&t=410)**\]:** While Fertig expected a lengthy cross-examination, the DEA only asked about three questions. They didn't attempt to dispute the negative side effects; instead, they simply established that marijuana doesn't directly kill people and has *some* medical utility. **Expert Concessions \[**[**15:28**](https://www.youtube.com/watch?v=iU6p-u9xiAQ&t=928)**\]:** A major moment involved Dr. Kenneth Finn, a pain management specialist testifying for the opposition. Under questioning from the DEA, he conceded that nobody has stopped breathing from cannabis use and admitted he would be open to prescribing it if it went through standard FDA approval processes \[[18:36](https://www.youtube.com/watch?v=iU6p-u9xiAQ&t=1116)\]. **Legal Strategy \[**[**13:09**](https://www.youtube.com/watch?v=iU6p-u9xiAQ&t=789)**\]:** Overhearing the opposition's lawyers after the hearing, Fertig noted they seemed to fully expect the DEA to go through with the rescheduling and were already preparing their strategy to appeal or challenge the decision in court later. **--------------** All in all, a favorable read from Natalie Fertig. My opinion \- It's the best we can hope for: an S3 rescheduling + follow up lawsuits to block it \- We can never expect SAM to stop challenging, it's the whole purpose of their existence \- The likelihood of an appeal working on this next year to me has no/little legal basis \- In the meantime the law will have to continue \- The separate legal thing happening on the bifurcation of medical/recreational and granting only S3 to medical is a potential blocker, but let's see In the end, if Trump wants this it will be unwise for Republicans to go against his wishes. In the judiciary as well, as we've seen with his comments on the Supreme Court. And Democrats generally have had a pro-cannabis stance so coming out against this is also unwise. SAM and the various anti-cannabis groups like pharma/alcohol will keep pushing this but that's not a new thing.. Trump would have known about SAM and the money behind them when he first signed the EO last year. Being denied on an issue like cannabis will make him look weak. And if Trump cannot bear one thing, it's looking weak. Imagine if the rescheduling gets blocked, the EOY election message will be "Trump can't even get cannabis rescheduled, and that's with the house/senate. If an issue like cannabis can't get sorted under this admin, what can?" It feels like it'll be somewhat turbulent and look uncertain but will come out favorable for rescheduling in the end. [](http://www.youtube.com/watch?v=iU6p-u9xiAQ)
The DEA rescheduling hearing is nearly over, with Wednesday marking the final day of testimony. Based on what we've heard, it has been a disaster for prohibitionists, who have made numerous mistakes and been repeatedly corrected by the administrative law judge.
I wanted to know how long after the hearings it will take to get final rule.........The below is AI While the Drug Enforcement Administration (DEA) hearings are scheduled to conclude no later than **July 15, 2026**, an immediate final ruling on adult-use/recreational cannabis will not happen overnight. Federal rulemaking requires a multi-step administrative process once the hearings wrap up. Here is the timeline of what has to happen next: # The Post-Hearing Process 1. **ALJ Recommendation (Weeks to Months):** After the hearing closes, Chief Administrative Law Judge (ALJ) Derek C. Julius must review the presented evidence, expert testimony, and hearing transcripts. He will then draft findings and a "recommended decision." There is no strict statutory countdown for this step—standard ALJ decisions often take 30 to 90 days, though complex federal dockets can take longer. 2. **DEA Administrator Review:** The ALJ’s recommendation is sent to the DEA Administrator, who reviews the findings to make a final determination. 3. **Final Rule Publication:** If the DEA decides to reschedule marijuana as a whole, they will draft and publish a Final Rule in the Federal Register. # The "Expedited" Factor This process is operating under an accelerated timeline. In December 2025, an Executive Order was issued directing the Attorney General to complete the rescheduling process "in the most expeditious manner in accordance with Federal law." Because of this mandate, the post-hearing review process will likely be compressed compared to traditional bureaucratic timelines. # Pending Legal Hurdles Even when the DEA issues a Final Rule for adult-use/recreational cannabis, it will not be the end of the road. When the Department of Justice issued its final order in April 2026 that immediately moved FDA-approved and state-licensed **medical** marijuana to Schedule III, multiple organizations and state attorneys general filed lawsuits in the D.C. Circuit Court of Appeals to block it. You should expect any final rule expanding Schedule III to adult-use cannabis to face immediate and aggressive legal challenges, which could delay the actual implementation.
There’s no reason for any stores to close yet. It’s up to state authorities first to make arrests, unless the DEA gets more funding and wants to get authoritative real quick like you all think. I’m looking at the glass half full, not half empty. This issue has been a rocky road for decades. Nothing new. Grab a joint and chill.
This is false. [Despite the April executive order, the US DEA.gov site still lists it as Schedule I as of July 13th, 2026.](https://www.dea.gov/drug-information/drug-scheduling)
It could have been completely descheduled like most drugs. Instead they put it in the same category as ketamine and anabolic steroids, drugs with medical use but high abuse potential. By law they have to be dispensed by a pharmacist for a valid prescription. The DEA literally investigates doctors who prescribe too many controlled substances. Why reschedule it instead of descheduling it unless you're going to crack down on it?
>DEA Marijuana Rescheduling Hearing Pauses for Day After Moving Ahead of Schedule...MH
So the honest timeline: Hearing concludes: ~July 15, 2026 Post-hearing briefs: weeks to ~2 months ALJ recommendation: weeks to months after that DEA Administrator's Final Rule (the actual "ruling"): plausibly late 2026, effective ~Q1 2027 on the expedited track Litigation: potentially extending durability well into 2027 or beyond So far the markets have waited until final ruling comes in, then there's a delay after that.
Recognizing your intended message was likely more that medical and rec can be in different schedules as an outcome - Fortunately DOJ / DEA / admin are very aligned (from all visible info) on broad shift to schedule 3…it doesn’t look like they have any intent for any other outcome Stylistically it’s not an admin that lets courts stop things where they can 😅 (which is wrong in most cases)…or that allows their agencies / circles to go against the admin For awhile all evidence (with a very uncertain timeline) has pointed to a final rule of S3 overall (no bifurcation of medical and rec). Unclear how strong the objections to the “process” are in court, but it seems evident that’s it’s those challenges that are the slow down / risk
>SAM Witness Acknowledges Marijuana Fits Schedule III Definition During DEA Rescheduling Hearing MH
NuggMD CEO Charlie Russell told Marijuana Moment, referring to news that the agency has been [focusing testimony on the medical benefits of cannabis and its relative safety](https://www.marijuanamoment.net/dea-and-fda-highlight-how-marijuana-is-safer-than-alcohol-and-opioids-during-rescheduling-hearings-opening-day/) "the testimony the DEA put on record has been more convincing than I think many consumers and stakeholders expected.” “Early reports have increased my confidence that the hearing will result in full rescheduling,” he said. MM
It's a good thing that at least the opposition to S3 on the ALJ is a bunch of incompetent morons that aren't making the case for schedule 2 then...But I wouldn't rule this scenario out just yet because this does sounds like the ideal compromised scenario that the DEA could favor.
Fun little tidbit of news unintentionally from from SAM. **The Schedule III "Gotcha" Moment**: During a remarkably brief, **five-minute cross-examination** by the DEA, Dr. Madros (SAM's star witness) was asked whether cannabis fits the legal definition of **Schedule III**, and she answered ***yes.***
My take on the low volume is bagholders (like me) are resigned to not selling before S3 hearings are done, and potential buyers are not willing to take a chance on what might possibly be yet another rug pull. The DEA is making the same argument I have been making; there is evidence of medical benefits, thus S3 across the board. I've never really understood the splitting between rec and medical, but others have showed a couple of other examples. So, despite every bone in my body wanting to hit the 'sell' button as I watch world events like Iran and Ukraine just continue to go on and on and on...I am holding out for these hearing to end. I am not expecting an announcement on 15 Jul, but I sure hope we get some decent clarity. What a journey. Glad to see Green Thumb making a decent move this morning.
I just got **all in** again on this one, doubled my money 2 times on OGI since covid on false corrections like are happening now (near 52 wks. low). Massively underpriced compared to other cannabis stocks and in my mind one of the only safe bets due to being backed by British American Tobacco. **Huge catalysts that will make this stock explode or at least regain it's price (double):** \-Current Market Cap ($CAD) +/- 195M, 2026 Guidance 350M+ \-Currently undervalued due to a sector wide correction non related to this company. \-They acquired several companies in legal markets (Canada, Germany) as well as the USA. \-Q3 (August 12th) will have a big revenue increase due to their buyout of Sanity Group in Germany's legal market (added revenue) \-USA ALJ DEA hearing (due date July 15th) for schedule 3 going in favor of Cannabis which will drive institutional investment later on as it finalizes & raise cannabis stocks as a whole later this month. \-BAT keeps investing in OGI at a strong double (true) valuation & who knows, they could acquire OGI completely later on (for long term investors). \-& tons more don't want to make this a book, you get the point, as always do your own research & draw your own conclusions, thought I'd share my recent research on this overlooked stock! This time there are much more catalysts than the last times I was invested in it.
Using the last of my Fable5 access ;) **The government came out swinging and rested fast.** The DEA's lead counsel opened by framing the entire hearing around "currently accepted medical use" (CAMU) — arguing that if even one accepted medical use exists, marijuana legally cannot stay in Schedule I. The government presented just two witnesses: Dr. Dominic Chiapperino of the FDA, who described the scientific process behind the Schedule III recommendation, and Dr. Corey Burchman, a pain physician who testified about transitioning patients from opioids to marijuana. The government rested its case-in-chief within four days. **Crucially, the legal framing favors rescheduling:** HHS's scientific and medical determinations on CAMU bind the DEA by statute, and Julius said he can't entertain arguments about whether the HHS two-part test is legally permissible. That dramatically limits what the opposition can attack. **The opposition has shifted strategy.** NDASA's witnesses focused on workplace drug testing and transportation safety rather than challenging the medical science — and legal observers note their arguments may do opponents more good in judicial review or public messaging than before the ALJ on the merits. Translation: they're building a record for the D.C. Circuit appeal, not trying to win the hearing. **SAM's Kevin Sabet is publicly rattled** — calling the government's testimony "surreal" and claiming they're "lying through their teeth". That's not what winning sounds like. **What's left:** SAM, DUID Victim Voices, Finn, Tennessee Bureau of Investigation, Drum, and the four states present after the recess — so this week through July 15. Updated odds: I'd nudge **Schedule III finalization up to \~85%**. The hearing is going about as well as the pro-rescheduling side could hope. The post-order Barr lawsuit remains the real fight.
Why are you making an argument that ignores both the Cali and Medellin cartels, and the DEA, and pretending the death of Escobar was the end of the story?
Judging by the price action the DEA has had a change of heart and are no longer the proponent of the S3 move... /s
More than a legit chance, that’s what the admin, DOJ, and now DEA are proposing
There is a massive Adderall and now Vyvanese shortage bc the DEA sets the amount allowed to be produced. They set it so Lowe for Adderall you get different manufacturers pills in your prescription if you can find it. This was like months ago and it's only gotten worse. People have turned to the dark web and while some of the fake Adderall that has been tested comes back as 100% amphetamine sulfate that's not what Adderall is. It is however safe compared to the pills that are part amphetamine sulfate & methamphetamine or just straight meth in pill form. Law of unintended consequences, they thought the black market wouldn't fill it with something worse. CIA & DEA motto: "Eradicating safer drugs since the 60s to overthrow governments, make room for even more dangerous drugs and precursors to flood the market & hurt those who need the medicine the most."
If the FDA approves it and the DEA grants licensing it can cross state lines. The real question is if this is going to be a part of the process. They can't force states where it's fully illegal to participate (just like there are dry counties or states with booze restrictions like Utah) but they can open up the market for those that have legalized it. A lot of questions still to be answered and it seems like this sub is mostly full of opinions.
The MM article “**DEA And FDA Highlight How Marijuana Is Safer Than Alcohol And Opioids During Rescheduling Hearing’s Opening Day” could be posted on r/NotTheOnion.**
Nope. Not recreational. I suggest go to the DEA website and review the definitions of a Schedule 1, 2, and 3 narcotic. Schedule 3 recognizes the medical aspect as well as less harmful effects than where it is at right now with Schedule 1. This is not legalization. That's not going to happen anytime soon in the good old land of the free. Best case scenario is Cannabis becomes a Schedule 3 narcotic, the big thing is this opens the door for better financing and further research. Anyone expecting full de-scheduling (legalization) from these hearings will likely be disappointed.
How does the cross-examination work? Like I get DEA as the principal proponent. I see cross examination supposedly starting at 1:00 PM. How will that be done? Will there be a single proxy for the opposition or will multiple opponents get to do separate crosses? How will proponents outside the government weigh in? By friend-of-the-court style briefs (they can’t let interested party present and finish in two weeks)? Will there then be dozens of briefs posted for every micro-level dispute? Or will they limit everyone to filing a single brief at the end of the evidentiary testimony?
“This hearing is NOT about recreational use, this is about rescheduling cannabis to schedule 3” - DEA lawyer Sounds very clearly like holistic, right off the bat 😁 Play it again, SAM
The DEA's high-profile cannabis rescheduling administrative law judge (ALJ) hearing starts today at **9:00 AM Eastern Time (ET)**. \[[1](https://www.dea.gov/sites/default/files/2026-06/Proposed%20Marijuana%20Rescheduling_Order%20re%20Detailed%20Hearing%20Schedule.pdf), [2](https://www.reddit.com/r/TLRY/comments/1ug6jus/top_5_things_to_know_about_the_june_29_dea/)\] Day 1 Schedule Details According to the official [Order Setting Schedule for Hearing Proceedings](https://www.dea.gov/sites/default/files/2026-06/Proposed%20Marijuana%20Rescheduling_Order%20re%20Detailed%20Hearing%20Schedule.pdf) issued by Chief ALJ Derek C. Julius, the timeline for the opening day unfolds as follows: \[[1](https://www.safeaccessnow.org/misguided_notions_of_alj_hearing_are_putting_cannabis_businesses_and_patients_at_risk), [2](https://www.cannabisbusinesstimes.com/cannabis-rescheduling/news/15828596/dea-judge-sets-cannabis-hearing-schedule-wont-consider-more-participants), [3](https://www.dea.gov/sites/default/files/2026-06/Proposed%20Marijuana%20Rescheduling_Order%20re%20Detailed%20Hearing%20Schedule.pdf)\] * **9:00 AM ET**: Chief ALJ opening statement * **9:30 AM ET**: Government opening statement * **9:45 AM ET**: Government's first witness direct examination * **12:00 PM ET**: Lunch break * **1:00 PM ET**: Cross-examination opportunities begin \[[1](https://www.dea.gov/sites/default/files/2026-06/Proposed%20Marijuana%20Rescheduling_Order%20re%20Detailed%20Hearing%20Schedule.pdf)\] Additional Trial Information * **Location**: The hearing is taking place live at the [DEA Hearing Facility](https://mmjnow.com/articles/june-29-rescheduling-hearing-preview) located at 700 Army Navy Drive in Arlington, Virginia. * **Public Access**: Chief Judge Julius ruled that the proceedings will **not be livestreamed** or broadcast over a public audio feed. * **Duration**: This expedited evidentiary trial runs from today through July 3, takes a brief holiday recess, and is scheduled to fully conclude by **July 15, 2026**
Are any of the old DEA "proponents" still involved? Id love to hear them forced to speak of the Benefits of cannabis ;)
It’s hard to believe that the DEA will give a pro-cannabis group time to testify.
Hoping someone can help me understand this. On April 23, 2026, the DOJ issued a final order that moved state-licensed medical cannabis and FDA-approved cannabis drugs from S1 to S3. For Trulieve and Glasshouse, who have successfully restructured (separating adult use from medical) and registered with DEA, their businesses are now federally compliant and meet the governance & regulatory compliance standards required for the NYSE listing. As I understand it, the combination of the state medical license + DEA registration and separation of adult use is what creates the new federally recognized framework for medical cannabis. In Theory, these companies should no longer face custody or banking issues, right? It may take time for banks and institutions to become comfortable and adjust their internal compliance but in theory if NYSE gave the green light, there should be obstacles legally? So assuming all cannabis is eventually fully rescheduled to S3 following this hearing and administrative process, and the DOJ issues a final rule/order that moves state-licensed ADULT use cannabis to S3, then these companies can simplify their structures and re-integrate the adult use operations. In essence wouldn’t this resemble something like a STATES 2.0 act minus the federal taxations and regulations? As long as a company is State licensed and DEA registered they would be federally compliant?
DEA announced info about the upcoming hearing. https://www.dea.gov/press-releases/2026/06/25/dea-hearing-proposed-marijuana-rescheduling-begins-june-29
I'm more optimistic about next week's hearing after seeing that the DEA has 6+ named attorneys on this. Lawyers have ethical duties to their client and it would be really murky if the DEA was actually looking to limpwrist this situation; it's one thing to convince one or a couple career attorneys to fake being a proponent, but this is a large group to expect to be tanking their own client's role in this. I'm bullish that DEA is at least looking to fight for this.
“[DEA is resisting a prohibitionist group’s request for an agency official to testify about the harms of marijuana](https://www.marijuanamoment.net/dea-resists-testimony-from-agency-official-linked-to-report-on-marijuanas-harms-during-rescheduling-hearing/) during the hearing. The DEA pharmacologist was previously an official witness for an earlier, subsequently cancelled hearing on marijuana rescheduling during the Biden administration. During that time, she submitted into the record a report that attempts to link cannabis consumption to psychosis, depression and impaired cognitive functioning. The prohibitionist organization Smart Approaches to Marijuana is attempting to call her for testimony during the current proceedings, but the agency is resisting that” —MM
We have the full **FUD** right now **Fear** that the DEA could pull more shenanigans **Uncertainty** of the proceedings as theres no live stream **Doubt** that change is happening in a timely manner.
The Drug Enforcement Administration (DEA) is resisting a prohibitionist group’s (SAM) request for an agency official, Luli Akinfiresoye, to testify about the harms of marijuana during a [hearing on the Trump administration’s move to reschedule cannabis](https://www.marijuanamoment.net/dea-judge-issues-order-laying-out-process-for-marijuana-rescheduling-hearing-starting-this-month/) that is scheduled to start next week. MM
its overtime and the DEA just said our team isnt allowed on the ice
I don't think it's that complicated. There's a split because we've had over a decade of states making state-legal recreational markets for cannabis. Having an accepted medical use is only one of many factors that are considered. Acceptable medical use only means that is not Schedule 1, not that it is Schedule 3. That's why fentanyl is Schedule 2 as a medical product. Extremely dangerous, but has a very widely accepted medical use. They literally just delineated between "recreational" fentanyl and "medical" fentanyl very recently, in regards to how it is treated by the federal government. The only difference in that case is that "recreational" fentanyl doesn't have a state legal framework, so there's no debate about it. What if California made a state legal fentanyl market? Would the federal government keep their hands off and treat them as selling a Schedule 2 substance? Or treat them as illegally selling a Schedule 1 substance and try to stop them? That's not even getting into the arguments that could be made about how most drugs are specific compounds, not a smokeable plant that can have a wide variety/potency of compounds simply depending on how it is grown. That's why CWEB is putting their drug through the botanical drug development pathway. The federal government can argue that without DEA oversight, they have no idea what cannabinoids are actually present in recreational cannabis. I don't know how it'll all shake out. But there are absolutely ways they could delineate between the two markets. Anyone acting like it's a done deal already is not assessing their risks properly.
Once again I find myself trying to follow the logic of how cannabis got split into medical and recreational in the first place. There is nothing in the DEA Scheduling definitions that breaks it down this way. The definition of Schedule 1 (directly from the DEA website) is: **Schedule I** Schedule I drugs, substances, or chemicals are defined as drugs with *no currently accepted medical use* and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote. "no currently accepted medical use" It seems to me that given "medical cannabis" is now Schedule 3, there is currently accepted medical use, ergo Schedule 3 applies across the board as accepted medical use is part of the core definition of S3. What am I missing? What is the point of these hearings? It would seem to me a fairly short conclusion that given the government recognized medical use in April then cannabis is Schedule 3. How did this become a medical/recreational split? For example, ketamine is Schedule 3, period. There is no delineation made between recreational and medical. Someone please make this make sense.
so then why were proponents at the previous ALJ hearings? Its certainly out of the norm. The DEA is rigging the deck.
The DEA isn’t allowing a single pro legalization party at the ALJ hearing
We are back to hoping the DEA doesn't screw the industry again.
Any potential catalyst before the 22nd ( deadline for DEA registration ). This beating is getting tiresome
The DEA has granted permission for VA researchers to import standardized marijuana extracts and THC for clinical trials, marking a significant regulatory shift in federal cannabis research policy. This authorization allows the VA to bypass current restrictions on domestic cannabis research materials, which have historically been limited to low-potency products from a single federal supplier. The move enables controlled studies using consistent, pharmaceutical-grade cannabis preparations that more closely mirror what patients actually use in legal states.
I still believe that we have a 75% chance of eventually rescheduling. But Im very aware that this is still a gamble. The DEA has proven time and time again that its willing to stifle progress. All it would take is the ALJ to rule ambiguously or punt to congress which would be a death sentence. Even expediated, government runs at a snails pace... and expect delays
Israel trying to break the peace deal. Same Israel that's going to merge into and have control over the CIA and DEA. Read up on it if it passes.
Which court case are you talking about? I wasn't talking about any cases. I'm saying the DEA administrative hearings beginning June 26. The hope is that they will result in rescheduling all cannabis regardless.of med/rec, in which case 280E would not apply to any of it. For now, 280E applies only to non-medical cannabis. MSOs don't have to deconsolidate to capitalize on this. They simply have.to account for the two channels separately.
Schedule 3 was with Trump's DEA longer than it was with Biden's DEA. The GOP Congress has done absolutely nothing. Have not even brought up SAFE for discussion in either House or Senate. The GOP have spent the last 15 years taking advantage of people not understanding how the Senate works. Just because the filibuster stops everything from passing doesn't mean the numbers aren't overwhelmingly in favor of Democrats supporting cannabis reform. If we'd replaced Chuck Schumer with a younger progressive Democrat instead of replacing him with John Thune, do you think we'd have better or worse chances at cannabis regulation coming from Congress?
Anyone who calls it deranged to call out a narcissist rapist pedophile is seriously as senile as he is. And any woman who supports him just so that she can get preferential DEA contracts is selling her soul for money.
DEA licenses given to Florida company. Preferential treatment to his favorite state. I don’t care how much money this stock makes now. They dead to me.
280e tax getting retroactively refunded. The first American Cannabis company to uplist to the NYSE. Just acquired over 200 DEA Licenses. See you in 5 days. Do what you like. 😃
The problem is that the DEA is running the hearings. They have proven to be inefficient if not impeding on rescheduling. History would tell us to expect setbacks.
So Trul is able to uplist without DEA approval, does this mean DEA approval is just a tick in the box exercise?
Schedule 3 was with Trump's DEA longer than it was with Biden's? This is all executive branch stuff. Congress is still overwhelmingly Democrats pushing for larger cannabis reform. Again i don't want to hear any complaining from you people when the GOP find a way to harm the recreational cannabis markets.
One thing I have to hand to DJT. He called out the DOJ (and DEA) for slow walking rescheduling. Biden and Harris wouldn't have done that.
Nice. I had forgotten about the DEA. Do you think they'll issue Federal compliance licenses? That could give Senior US exchanges the comfort they need
This is the most likely thing, as it's still pending while we are all waiting for the ALJ hearings to start. DEA approving MSOs registrations is another one, I suspect that Trulieve and Curaleaf will be the first MSOs to be approved, but we are still half-way across the 60-day approval period.
That Oracle account tweeted again. Feels disingenuous... "DEA: The \[rescheduling\] process is being carried out" [https://x.com/OracleNYSE/status/2060065088065716345](https://x.com/OracleNYSE/status/2060065088065716345)
Why flyin' high today? This is what I got, let me know..... 1) Today was effectively the deadline for participation/objections in the DEA Schedule III hearing process (and appears no big coordinated opposition?) ... more likely smooth sailiing than not for the June 29 DEA hearing. 2) The Curaleaf uplisting/ADR angle ..... access to more $$$, it was out 1-2 days ago, but coupled with the above, has led to it being more credible.
The room is full of smoke and mirrors and Trump has made medicinal cannabis semi legal while maintaining recreational as illegal Add to this is the Hemp/cannabis confusion with McConnells Farm bill and then throw everything at the DEA and let them review everything WTF
There would have to be a federal mandate as schedule 3 does not open up interstate commerce even if cannabis as a whole gets rescheduled, it will become a FDA/ DEA pipeline issue
here we go: **Immediately after July 15** The ALJ writes up findings and recommendations. This is not a quick process even under pressure — expect 2-4 weeks minimum. The ALJ has to summarize the entire hearing record, assess witness credibility, evaluate competing evidence, and make recommendations to the DEA Administrator. Realistically that lands on the Administrator's desk sometime in early to mid August. **The Administrator's review** Terry Cole then has to review the entire record — the ALJ findings, all 43,000 public comments, the HHS scientific recommendation, the hearing testimony — and decide whether to publish a final rule. There's no hard deadline on this step. That's actually the soft underbelly of the entire timeline. The expedited hearing has a hard July 15 deadline. The Administrator's review does not. Under political pressure from the White House — which has already demonstrated it will publicly complain about slow-walking — Cole would be expected to move quickly. But quickly here probably means 4-6 weeks not 4-6 days. So realistically a final rule gets published somewhere between late August and late September. **The 30-90 day effective date window** Once the final rule is published it needs a minimum 30-day effective date under the APA. The DEA already argued this is not a major rule under the CRA so they're claiming the 60-day Congressional Review window doesn't apply. SAM will dispute that. If DEA is right — 30 days minimum. Final rule effective late September to October. If SAM convinces a court it's a major rule — 60-day Congressional Review window kicks in on top of the 30-day APA minimum. That pushes effectiveness to November or December.
Are they saying that the DEA has accepted their application and issued the federal DEA license, or just that they completed the application process. Either this release is ambiguous or I haven't had my coffee.
First mover advantage on DEA registration is actually a big deal. Sets them up well for whatever federal framework comes next. Curious how long before other MSOs follow suit.
TSA was never going to arrest you unless it was enough drugs to refer to DEA, they always just called local police. At SFO and OAK it was official policy to not bother police for less than 8 ounces since at least 1998 after prop 215 passed since local police wouldn't do anything as it was legal.
The DEA isn’t who made weed schedule 1. It was an act of congress. It is the only schedule 1 drug mandated to be schedule 1 by law. It’s meant to target people of a certain skin color, so of course republicans won’t do anything about it.
The Drug Enforcement Administration (DEA) says a question on its new medical marijuana registration form asking applicants if they previously handled controlled substances without federal authorization is not intended to block state-licensed businesses from receiving registration. The agency added that the broader registration process is designed to evaluate applicants based on their current ability to operate within the federal framework. MH
The rescheduling for medical has already occurred. DEA is holding hearings on non-medical next month and there is a bill in the house that would grant adult use non medical schedule III status. (Not a given some of the house are anti cannabis) But the schedule III for medical is a big win for the big 3 cannabis companies, their tax relief is hundreds of millions. I think the big institutions are holding back waiting for a safe harbor ruling/memo. Otherwise the big banks can’t hold their shares for them.
From what I've been reading around, it seems that safe banking won't be really necessary once the DEA gives their approval. But I wouldn't oppose getting the bill passed by the Senate, we could use with the redundancy in case the S3 process gets stayed again.
And Green Thumb was always in the USA. It really seems that when the DEA gives their acceptance to these companies, they should be able to uplist fast. Side note, Verano has submitted their application with the DEA today https://x.com/i/status/2054540393522278513
TLDR: * Cannabis was partially moved to Schedule III * This mainly applies to FDA-approved cannabis drugs and state medical cannabis businesses * Recreational/adult-use cannabis is still Schedule I * Medical operators may get 280E tax relief starting in 2026 * Medical operators must register with the DEA * This does not federally legalize cannabis * This does not fix banking or pass SAFE Banking * DOJ is still reviewing whether all cannabis, including adult-use, should move to Schedule III * Legal challenges are likely
I wanna see some reports of CEOs conversations with the SEC about uplifting. I wonder when that's gonna start? As their DEA applications get approved?
The House Appropriations Committee directs the Drug Enforcement Administration (DEA) and Food and Drug Administration (FDA) to address the “proliferation of Federally unregulated ingestible, inhalable, and topical products that contain intoxicating cannabinoids.” MM
DEA, this must be the infamous cocaine bear. I heard he used to be a brown before all the cocaine dyed his fur.
It seems as though this sector always has some carrot on the end of a stick that turns into nothing more than a sell the news event. I am surprised there is not more discussion on this subreddit about the upcoming rec S3 hearings in July. On the one hand, I have a hard time believing Republicans (or SAM) will let this through. Trump has already made it clear he is not in favor of rec. On the other hand, the very definition of S1 is "drugs with no currently accepted medical use". It would seem the recent med S3 ruling supports S3 overall. S3 is defined as "drugs with a moderate to low potential for physical and psychological dependence". I believe SAM will argue high potential for dependence But I find it interesting the DEA definitions do not delineate between medical and recreational. As well, there has been no discussion about whether hemp derived cannabis will be banned or better regulated come November. My guess is better regulated. A lot of farmers switched to growing hemp BTW, it strikes me as though there are only about a dozen or so regular contributors to this subreddit left. Personally I am not as engaged (or heavily invested) as I used to be. For me it's been over 8 years of mostly rug pulls. Can this sector ever move beyond success being "just around the corner?" 🚀
I don’t know what ur talking about. The DEA isn’t moving to do anything. Medical marijuana is now federally legalized across the board. The DEA is simply approving companies that apply and are eligible. There is zero conversation about certain products. Please send a link if you have one. But I know you don’t. See you in 8 weeks!
> Medical marijuana was just federally legalized my dude Oh my sweet, sweet summer child. No, the DEA is moving to make *some products* schedule 3. that doesn't make "medical marijuana legal". >Adult use / recreational is also about to be federally legalized (schedule iii) in July. AHAHAHAHA. OK ging3r_gin3r. I'll check back in with you in 6 weeks about that one.
…are. Are you joking or just being disingenuous? Medical marijuana was just federally legalized my dude. How is that not progress? Adult use / recreational is also about to be federally legalized (schedule iii) in July. This is incredible progress for a drug that’s been demonized forever. The MSOs are literally applying to the DEA as we speak because they are indeed adhering to the level playing field that regulations have created. I’m so confused. Have you been living under a rock?
I wonder what the impact of being listed on TSX will be for Curaleaf and Terrascend when/if all cannabis is rescheduled and DEA licenses have been issued. Will it make it faster for them to uplist? Curaleaf shareholders will vote on June 22 to redomicile in Delaware so there's that too.